| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 9 |
| NetGPI | no | yes: 0, no: 9 |
Related structures:
AlphaFold database: Q4QF02
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 142 | 146 | PF00656 | 0.657 |
| CLV_NRD_NRD_1 | 96 | 98 | PF00675 | 0.607 |
| CLV_PCSK_KEX2_1 | 122 | 124 | PF00082 | 0.683 |
| CLV_PCSK_PC1ET2_1 | 122 | 124 | PF00082 | 0.683 |
| CLV_PCSK_SKI1_1 | 106 | 110 | PF00082 | 0.562 |
| CLV_PCSK_SKI1_1 | 125 | 129 | PF00082 | 0.684 |
| DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.700 |
| DOC_CKS1_1 | 12 | 17 | PF01111 | 0.698 |
| DOC_MAPK_gen_1 | 104 | 111 | PF00069 | 0.658 |
| DOC_USP7_MATH_1 | 150 | 154 | PF00917 | 0.495 |
| DOC_WW_Pin1_4 | 11 | 16 | PF00397 | 0.577 |
| DOC_WW_Pin1_4 | 128 | 133 | PF00397 | 0.761 |
| LIG_14-3-3_CanoR_1 | 6 | 15 | PF00244 | 0.749 |
| LIG_14-3-3_CterR_2 | 156 | 158 | PF00244 | 0.601 |
| LIG_BRCT_BRCA1_1 | 41 | 45 | PF00533 | 0.730 |
| LIG_FHA_2 | 12 | 18 | PF00498 | 0.710 |
| LIG_FHA_2 | 147 | 153 | PF00498 | 0.497 |
| LIG_FHA_2 | 55 | 61 | PF00498 | 0.557 |
| LIG_LIR_Apic_2 | 10 | 15 | PF02991 | 0.698 |
| LIG_LIR_Gen_1 | 62 | 72 | PF02991 | 0.684 |
| LIG_LIR_Nem_3 | 62 | 67 | PF02991 | 0.657 |
| LIG_SH2_CRK | 64 | 68 | PF00017 | 0.669 |
| LIG_SH2_PTP2 | 12 | 15 | PF00017 | 0.695 |
| LIG_SH2_STAT5 | 12 | 15 | PF00017 | 0.672 |
| MOD_CK1_1 | 11 | 17 | PF00069 | 0.734 |
| MOD_CK1_1 | 121 | 127 | PF00069 | 0.678 |
| MOD_CK1_1 | 133 | 139 | PF00069 | 0.519 |
| MOD_CK1_1 | 33 | 39 | PF00069 | 0.627 |
| MOD_CK1_1 | 88 | 94 | PF00069 | 0.709 |
| MOD_CK2_1 | 128 | 134 | PF00069 | 0.762 |
| MOD_CK2_1 | 146 | 152 | PF00069 | 0.481 |
| MOD_CK2_1 | 33 | 39 | PF00069 | 0.740 |
| MOD_CK2_1 | 54 | 60 | PF00069 | 0.550 |
| MOD_GlcNHglycan | 134 | 138 | PF01048 | 0.582 |
| MOD_GlcNHglycan | 32 | 35 | PF01048 | 0.617 |
| MOD_GlcNHglycan | 87 | 90 | PF01048 | 0.741 |
| MOD_GSK3_1 | 109 | 116 | PF00069 | 0.524 |
| MOD_GSK3_1 | 146 | 153 | PF00069 | 0.497 |
| MOD_GSK3_1 | 26 | 33 | PF00069 | 0.647 |
| MOD_GSK3_1 | 35 | 42 | PF00069 | 0.645 |
| MOD_GSK3_1 | 4 | 11 | PF00069 | 0.712 |
| MOD_GSK3_1 | 56 | 63 | PF00069 | 0.544 |
| MOD_N-GLC_1 | 150 | 155 | PF02516 | 0.496 |
| MOD_NEK2_1 | 109 | 114 | PF00069 | 0.642 |
| MOD_NEK2_1 | 45 | 50 | PF00069 | 0.537 |
| MOD_NEK2_1 | 67 | 72 | PF00069 | 0.569 |
| MOD_PIKK_1 | 109 | 115 | PF00454 | 0.586 |
| MOD_PKA_2 | 60 | 66 | PF00069 | 0.670 |
| MOD_Plk_2-3 | 130 | 136 | PF00069 | 0.727 |
| MOD_Plk_4 | 26 | 32 | PF00069 | 0.466 |
| MOD_Plk_4 | 8 | 14 | PF00069 | 0.733 |
| MOD_ProDKin_1 | 11 | 17 | PF00069 | 0.578 |
| MOD_ProDKin_1 | 128 | 134 | PF00069 | 0.762 |
| TRG_ENDOCYTIC_2 | 64 | 67 | PF00928 | 0.661 |
| TRG_ENDOCYTIC_2 | 99 | 102 | PF00928 | 0.655 |
| TRG_ER_diArg_1 | 123 | 126 | PF00400 | 0.718 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A1X0NG26 | Trypanosomatidae | 32% | 85% |
| A0A3S7WTR1 | Leishmania donovani | 86% | 100% |
| A0A422NDE0 | Trypanosoma rangeli | 36% | 84% |
| A4HWR7 | Leishmania infantum | 85% | 100% |
| C9ZW57 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 33% | 80% |
| E9AI52 | Leishmania braziliensis | 89% | 86% |
| E9AQH5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
| V5AP83 | Trypanosoma cruzi | 36% | 84% |